You Searched For "astrazeneca pharma" and got 20 results
Sort By:
AstraZeneca agrees to make COVID-19 vaccine for Europe
"This agreement will ensure that hundreds of millions of Europeans have access to Oxford University…
PTI
AstraZeneca says it's developing a 'next generation' COVID-19 vaccine to target fast-spreading variants, and it could be ready by Autumn
AstraZeneca hopes it new vaccine could protect against coronavirus variants, which some experts wor…
Dr. Catherine Schuster-Bruce
Healthcare is Amazon and Walmart's latest battleground
These are Insider's biggest healthcare stories for May 11.
Lydia Ramsey Pflanzer
Haven, the Amazon-Berkshire Hathaway-JPMorgan health venture, is disbanding
These are Business Insider's biggest healthcare stories for January 5.
Lydia Ramsey Pflanzer
AstraZeneca's stock jumps after the UK authorizes emergency use of its vaccine, which it created with Oxford University
The AstraZeneca and Oxford University vaccine is easy to store and requires standard refrigeration,…
Shalini Nagarajan
I'm a neurologist who happily volunteered for the AstraZeneca vaccine trials. Here's what people are getting wrong about the process.
Scientists were not starting from scratch, writes Jonathan Howard, who is "very optimistic we'll be…
Jonathan Howard, MD
How Lufthansa Cargo will ship up to 10 million COVID-19 vaccine doses a day
We went inside Lufthansa Cargo's facility at O'Hare International Airport to see how the team prepa…
Medha Imam,Clancy Morgan,Shir…
How many coronavirus vaccine doses each US state will get to start
The federal government is allocating COVID-19 vaccine doses to states according to their population…
Mary Meisenzahl
We're on the cusp of vaccine authorizations
These are the top stories written by Business Insider's healthcare team for the week ending Decembe…
Lydia Ramsey Pflanzer
Serum Institute of India threatens to seek ₹100 crore in damages from Chennai volunteer
The SII stated that the medical team informed the volunteer that the complications were unre…
Top stock movers — Future Retail, AstraZeneca, Cadila, DHFL, M&M, Indraprastha Gas, Gujarat Gas, Mahanagar Gas, and others
Indian equity benchmark indexes opened on a tepid note on Friday, tracking subdued cues from global…
AstraZeneca slides after announcing its COVID-19 vaccine candidate is 70% effective
The Oxford/AstraZeneca vaccine is cheaper to produce than Pfizer and Moderna's, but is clearly less…
Shalini Nagarajan
AstraZeneca and Oxford University's vaccine is effective at preventing COVID-19, trial results suggest. Here's everything we know so far.
AstraZeneca and The University of Oxford's covid-19 vaccine is 70% effective, the groups say. Here'…
Spriha Srivastava
A 3rd coronavirus vaccine works
These are Business Insider's biggest healthcare stories for November 23.
Lydia Ramsey Pflanzer
AstraZeneca gets marketing permission for leukaemia drug in India
"This is to inform that AstraZeneca Pharma India Limited has received import and market permission…
PTI
Bill Gates says several more COVID-19 vaccine frontrunners will likely be highly effective, boosting worldwide access to a shot
These vaccines, developed by AstraZeneca, Novavax, and J&J,"are a little bit easier to scale up pro…
Andrew Dunn
Pfizer and Moderna hiked their COVID-19 vaccine prices in the EU after AstraZeneca lost popularity there, report says
The reported new contracts come as experts mull booster shots to combat the fast-spreading Delta co…
Ashley Collman
'That model is not sustainable': Pharma giants AstraZeneca and Merck are sounding the alarm on the middlemen who stand between drug makers and patients
Dobber pointed to other members of the pharmaceutical industry - so-called middlemen - and the reba…
Lydia Ramsey
Global stocks slide as France, Spain, and the UK record thousands of new COVID-19 cases
European bank shares tumbled following reports that they moved large sums of suspicious transaction…
Shalini Nagarajan
We spoke to the president of AstraZeneca about the pharma giant's plans to get back to growth after losing billions in sales to generic competition
In 2011, at its peak, AstraZeneca was making $33.6 billion in revenue. In 2017, that was down to $2…